quantisnow
FeedTopReportsPricing
⌘K
Live feed
13:23:29·808d
NEWSRelease
23andMe Holding Co. logo
Natera Inc. logo
Invitae Corporation logo

SoftBank-Backed Genetic Testing Invitae's Descent from $7B Valuation to Near-Bankruptcy

ME· 23andMe Holding Co.NTRA· Natera Inc.NVTA· Invitae Corporation
Health Care
Original source

Companies

  • ME
    23andMe Holding Co.
    Health Care
  • NTRA
    Natera Inc.
    Health Care
  • NVTA
    Invitae Corporation
    Health Care

Recent analyst ratings

  • Apr 14NTRAUpdateWilliam Blair-
  • Jan 7NTRAUpdateCitigroup$300.00
  • Dec 2NTRAUpdateMorgan Stanley$265.00
  • Oct 27NTRAUpdateBNP Paribas Exane$172.00
  • Sep 22NTRAUpdateWells Fargo$175.00
  • Mar 13NTRAUpdateRBC Capital Mkts$251.00

Related

  • SEC9h
    SEC Form DEFA14A filed by Natera Inc.
  • SEC9h
    SEC Form DEF 14A filed by Natera Inc.
  • INSIDER2d
    SEC Form 4 filed by Sheena Jonathan
  • ANALYST9d
    William Blair initiated coverage on Natera
  • PR10d
    Natera Highlights Positive Interim Futility Analysis from Allogene Therapeutics' MRD-Guided ALPHA3 Trial in Large B-Cell Lymphoma
  • INSIDER14d
    SEC Form 3 filed by new insider Rubin Eric H
  • PR14d
    Judge Awards 30% Ongoing Royalty to Natera for its MRD-Related Patents
  • INSIDER15d
    SEC Form 4 filed by Rabinowitz Matthew
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022